首页> 外文期刊>NeuroImage: Clinical >Progressive brain atrophy and clinical evolution in Parkinson’s disease
【24h】

Progressive brain atrophy and clinical evolution in Parkinson’s disease

机译:帕金森病的进步性脑萎缩与临床演变

获取原文
       

摘要

Clinical manifestations and evolution are very heterogeneous among individuals with Parkinson’s disease (PD). The aims of this study were to investigate the pattern of progressive brain atrophy in PD according to disease stage and to elucidate to what extent cortical thinning and subcortical atrophy are related to clinical motor and non-motor evolution. 154 patients at different PD stages were assessed over time using motor, non-motor and structural MRI evaluations for a maximum of 4?years. Cluster analysis defined clinical subtypes. Cortical thinning and subcortical atrophy were assessed at baseline in patients relative to 60 healthy controls. Longitudinal trends of brain atrophy progression were compared between PD clusters. The contribution of brain atrophy in predicting motor, non-motor, cognitive and mood deterioration was explored. Two main PD clusters were defined: mild (N?=?87) and moderate-to-severe (N?=?67). Two mild subtypes were further identified: mild motor-predominant (N?=?43) and mild-diffuse (N?=?44), with the latter group being older and having more severe non-motor and cognitive symptoms. The initial pattern of brain atrophy was more severe in patients with moderate-to-severe PD. Over time, mild-diffuse PD patients had the greatest brain atrophy accumulation in the cortex and the left hippocampus, while less distributed atrophy progression was observed in moderate-to-severe and mild motor-predominant patients. Baseline and 1-year cortical thinning was associated with long-term progression of motor, cognitive, non-motor and mood symptoms. Cortical and subcortical atrophy is accelerated early after the onset of PD and becomes prominent in later stages of disease according to the development of cognitive, non-motor and mood dysfunctions. Structural MRI may be useful for monitoring and predicting disease progression in PD.
机译:临床表现和进化在帕金森病(PD)中的个体中是非常异构的。本研究的目的是根据疾病阶段研究PD的渐进性脑萎缩的模式,并阐明皮质稀释和皮质萎缩与临床电机和非运动进化有关的程度。使用电动机,非电动机和结构MRI评估最多4年来评估不同PD阶段的154例不同PD阶段的患者。聚类分析定义了临床亚型。在相对于60例健康对照中,在患者的基线评估皮质稀释和皮下萎缩。在PD簇之间比较了脑萎缩进展的纵向趋势。探讨了脑萎缩在预测电动机,非运动,认知和情绪恶化中的贡献。定义了两个主要的PD簇:温和(n?=?87)和中度至严重(n?=Δ67)。进一步鉴定出两种温和亚型:温和的电动机 - 主要(n?=Δ33)和轻度 - 漫射(n?=Δ44),后者群体较旧,具有更严重的非运动和认知症状。中度至重度PD患者脑萎缩的初始模式更严重。随着时间的推移,轻度弥漫性PD患者在皮质和左海马中具有最大的脑萎缩积聚,而在中度至严重和轻度电动机 - 主要患者中观察到较少分布的萎缩进展。基线和1年皮质细化与电机,认知,非运动和情绪症状的长期进展相关。皮质和皮质萎缩在PD发作后早期加速,并根据认知,非运动和情绪功能障碍的发展,在疾病的后期突出。结构MRI可用于监测和预测PD中的疾病进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号